Carl L. Gordon - 16 Jun 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director, 10%+ Owner
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Carl Gordon
Issuer symbol
TERN
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
21 Jun 2022, 21:00:32 UTC
Previous filing
15 Jun 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +32,000 $0.000000 32,000 16 Jun 2022 Common Stock 32,000 $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant.